Skip to content
Scientists using the CRISPR-Cas9 gene-editing technology say they can treat mice to reverse the deterioration that takes place after a heart attack. Their research […]
CRISPR post-heart attack therapy suggests new uses for gene editing Read More »
The “benefits” pharmacy benefit managers (PBMs) once provided have been lost, as these organizations now mostly help themselves while driving up drug prices, said
Senate hearing looks at what went wrong with PBMs Read More »
The threat of expanding intellectual property waivers by the World Trade Organization (WTO) dampens investment in research, Biotechnology Innovation Organization’s (BIO) Chief Policy Officer
BIO opposes extension of WTO IP waiver in federal hearing Read More »
The impact of drug price controls on innovation, market distortions caused by pharmacy benefit managers (PBMs), and the importance of accelerated approval came up
House 2024 health budget hearings touch on price controls and PBMs Read More »
The Council of State Bioscience Associations (CSBA), a coalition of state-based bioscience trade associations convened by the Biotechnology Innovation Organization (BIO), joined forces in
CSBA hits Capitol Hill for face time with lawmakers Read More »
Legislation that has been reintroduced in the Senate and has the support of the Biotechnology Innovation Organization (BIO) is set to enhance research, an
R&D in biotech gets a boost with reintroduced bill Read More »
The Accelerated Approval pathway was established by the U.S. Food and Drug Administration (FDA) in the 1990s to boost R&D for HIV/AIDS, and the
I am BIO Podcast: Accelerated Approval, accelerating hope Read More »
According to a recent report from the Centers for Disease Control and Prevention (CDC), drug-resistant Candida auris (C. auris) fungus cases “spread at an
Drug-resistant C. auris fungi cases tripled in 2021 says CDC Read More »
The Department of Health and Human Services (HHS) and Department of Commerce (DOC) will investigate using Bayh-Dole march-in rights as a way to control
HHS investigating using Bayh-Dole march-in rights for price controls Read More »
Following her appearance before the Senate Finance Committee on Thursday, U.S. Trade Representative Ambassador Katherine Tai revisited the administration’s trade policy agenda on Friday
Biotech corn in the spotlight; USTR pledges to use all USMCA tools Read More »
